'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.
about
Harm reduction and knowledge exchange-a qualitative analysis of drug-related Internet discussion forumsRecreational use, analysis and toxicity of tryptaminesCommon causes of poisoning: etiology, diagnosis and treatment.Rapid screening and determination of 11 new psychoactive substances by direct analysis in real time mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.Using poisons information service data to assess the acute harms associated with novel psychoactive substances.Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation.A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug.Synthetic cathinones and their rewarding and reinforcing effects in rodents.Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice.Analysis of the first- and second-generation Raving Dragon Novelty Bath Salts containing methylone and pentedrone.The hallucinogenic world of tryptamines: an updated review.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with humEthylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.A cluster randomised controlled trial of the Climate Schools: Ecstasy and Emerging Drugs Module in Australian secondary schools: study protocol."Chasing the high" - experiences of ethylphenidate as described on international internet forumsIn vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review.'Legal high' associated Wallenberg syndromeUse of novel psychoactive substances by inpatients on general adult psychiatric wardsMethoxetamine (MXE)--a phenomenological study of experiences induced by a "legal high" from the internetPostmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.Poisoning with illicit substances: toxicology for the anaesthetist.Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.Stakeholders' Views on Barriers to Research on Controversial Controlled Substances.Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.A novel psychoactive substance poses a new challenge in the management of paranoid schizophreniaUsing internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4'-dimethylaminorex.Using journal review articles to increase the dissemination of keynote and symposia lectures at international medical congresses.Psychoactive Substances Bill and Act of New Zealand: A Chance to Engage Undergraduate Scientists with Society using a Transfer Learning Paradigm.Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.An accidental fatal intoxication with methoxetamine.GC-MS, LC-MS(n), LC-high resolution-MS(n), and NMR studies on the metabolism and toxicological detection of mesembrine and mesembrenone, the main alkaloids of the legal high "Kanna" isolated from Sceletium tortuosum.The effects and toxicity of cathinones from the users' perspectives: A qualitative study.An Impaired Driver Found to be Under the Influence of Methoxetamine.Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample.Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial.
P2860
Q21245634-E8C54584-1001-4A58-B451-3573C72BD909Q27027080-AF183E7B-82E7-49CA-BA95-259B1610561BQ27692613-CD3E0764-74B1-4485-ADFC-55D61ADACA99Q30391977-3BDEEB5C-8B10-43D1-A543-A85892B9507DQ30821795-4DF2462E-7406-4593-9936-88E700A80ED4Q30866147-0C90C85B-CB0B-4C68-A28D-3FFD4A4E5FEAQ33829385-5F0F3A9B-4701-47C4-998C-330ADD7A18DAQ34274260-500022F1-B641-479E-AE3C-813F776F0013Q34331924-4882CA0C-9761-41D5-AA7F-9B296ADD9D8BQ34352354-1E30897E-6AD7-45ED-A826-7A04E4D21ACDQ34407467-1667778D-9988-4393-A795-DB3427784B5BQ34451847-30408270-88B7-4897-9A61-EF6D27F597EEQ34471834-A965CEAF-2406-4D7A-997B-AE288C0A67C1Q34514221-10959E21-E78B-4965-9D74-1F8125540537Q34543628-187408F9-52B4-4ADB-AF38-7D0189FA14A6Q35065250-BAC1C763-540C-4B4E-A4DE-3913FAFF71C0Q35161756-17B0BFF4-5961-4B9F-996E-532169BAC1B3Q35779974-E0B88626-C563-429E-8403-030E69B3E749Q36410928-DAC8601A-F36C-4E65-B9D8-A5B54DF1146BQ36894102-9F37FA6A-57B4-48D3-A4C7-4AFA7A100894Q36920246-AA269A8D-0D0B-49A0-9CF9-0BB8985C1133Q37130557-55ACF94A-FC07-46A6-B3B3-D543EDF7CE57Q37672302-E7095DEE-3A51-4CBC-8824-269365207496Q37728569-99A2663F-DEB6-4B38-834C-64A007384654Q38064910-BE1FD869-CC82-4C6A-8513-9A7C40594D8DQ38551229-5CF386DF-112A-4967-929D-4894C21B826FQ39046023-0196C375-5154-4DB0-A387-6E5899241439Q40715040-CC551D1D-8D60-47CA-A6D0-AF1B54C58636Q40747227-10C1B5DE-7095-4DC9-B24F-FC99ADC6E282Q42559016-B184CEEA-95DE-41E2-881C-0AEAC50923C6Q42869549-9CACFDF4-F9D8-4406-AEC4-534F966D9E7EQ43181208-442C520F-225E-46FF-8E6D-FA0743966535Q43977082-568E3B14-3BAC-4DA4-872A-F3A9F67BDF3EQ44806049-A2387BAC-FBFE-4860-8CE7-05826CE6BBC3Q46193644-C608FCD7-BEE6-4330-ACB8-529BEEFB9BFBQ46836046-4F05D571-0611-4C0A-8F0E-4B2E4C96E02EQ47206714-EE63CB5E-EAF3-452C-AE36-4D9E781FE3C6Q47416722-AB77EF74-118D-4638-AB3D-DAD8F44BC582Q47661368-87A6035F-F76B-49C0-8B3B-77566155F748Q47884497-DD2D2322-66DD-475F-A01C-ED80B38AE975
P2860
'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
'Legal highs'--novel and emerg ...... overview for the toxicologist.
@en
'Legal highs'--novel and emerg ...... overview for the toxicologist.
@nl
type
label
'Legal highs'--novel and emerg ...... overview for the toxicologist.
@en
'Legal highs'--novel and emerg ...... overview for the toxicologist.
@nl
prefLabel
'Legal highs'--novel and emerg ...... overview for the toxicologist.
@en
'Legal highs'--novel and emerg ...... overview for the toxicologist.
@nl
P2860
P1433
P1476
'Legal highs'--novel and emerg ...... overview for the toxicologist.
@en
P2093
Simon Gibbons
P2860
P356
10.3109/15563650.2011.645952
P407
P577
2012-01-01T00:00:00Z